Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top London based Founder operating in the Medical space. If you think a Founder is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Yusuf Sherwani
Co-Founder & CEO of Quit Genius
Yusuf is the Co-Founder and CEO of Quit Genius. He is a Y Combinator alumni and was featured by Fast Company’s as one of their Most Creative People of 2019 as well as Forbes’ 30 Under 30 List of 2018.
Follow Yusuf Sherwani:
About Quit Genius: Quit Genius is pioneering digital therapeutics for multiple addictions.
_______
Andre Chow
Co-Founder & Co-CEO of Digital Surgery
Andre is a General Surgeon, Web coder, UX designer and all-round hacker. He has a BSc in Surgical Technology, a PhD in Tissue Engineering and leads Operations & Product. When not in the lab, Andre spends his spare time playing a variety of sports, and trying to push his french bulldog off the sofa.
Follow Andre Chow:
About Creative Destruction Lab (CDL), Digital Surgery, Medtronic, Touch Surgery: Digital Surgery is a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training
Peter Hames
Co-Founder & CEO of Big Health
Peter Hames is CEO of Big Health, a digital medicine company he co-founded with clinical psychologist Prof Colin Espie (University of Oxford). Big Health creates automated behavioral medicine programs fuelled by tracked data, and was inspired by Peter’s difficulty in getting access to evidence-based non-drug solutions to his own insomnia. Big Health’s first product, Sleepio, is a digital sleep improvement program featuring personalized Cognitive Behavioral Therapy (CBT) techniques, delivered by virtual animated sleep expert The Prof and his narcoleptic dog Pavlov. In the world’s first placebo-controlled randomised trial for an intervention of its kind, Sleepio was shown to be comparable in effectiveness to face-to-face therapy.
Follow Peter Hames:
About Big Health, Lucky Voice, NHS England, Sleepio: Big Health is a digital therapeutics company operating a healthcare portal to offer behavioral programs for mental health issues.
Peter Ward
CEO and Co-Founder of Humanity
Peter Ward is a Co-Founder and Chief Executive Officer at Humanity.
Follow Peter Ward:
About Humanity: Humanity is a healthcare company that aims to extend the healthspan of humanity.
Gabriella Santosa
Co-Founder and CSO of Puraffinity
Follow Gabriella Santosa:
About Puraffinity: Puraffinity develops precision materials to target chemicals, with an initial focus on PFAS in water
Henrik Hagemann
CEO and Co-Founder of Puraffinity
Follow Henrik Hagemann:
About Puraffinity, Tech London Advocates: Puraffinity develops precision materials to target chemicals, with an initial focus on PFAS in water
Luke Heron
Co-Founder of TestCard Ltd
Luke Heron co-founded TestCard.com, a UK domiciled startup revolutionising the direct to consumer healthcare diagnostics market.
Follow Luke Heron:
About TestCard Ltd: TestCard is the medical technology company behind the eponymous at-home test kit. A partnering mobile app delivers immediate results.
Houman Ashrafian
Managing Partner & Founder of SV Health Investors
Houman Ashrafian is the Managing Partner at SV Health Investors.
Follow Houman Ashrafian:
About Catamaran Bio, Cellinta, Enara Bio, Karus Therapeutics, Sitryx Therapeutics, SV Health Investors, Zarodex Therapeutics: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Gregg Sando
Founder & former Chief Executive Officer of Kuur Therapeutics
Gregg Sando is the founder and CEO of Cell Medica. After a career in investment banking based both in London and New York, he completed his Immunology MSc degree at the medical school of Imperial College. Recognizing the significant progress taking place in the field of cellular immunotherapy, Gregg formed Cell Medica in cooperation with a small group of the leading clinicians and immunologists who were pioneering this new mode of medical treatment. (B.A. Biochemistry, Harvard University; M.B.A. University of Chicago; MSc Immunology, Imperial College London).
Follow Gregg Sando:
About Kuur Therapeutics: Kuur Therapeutics is committed to transforming the lives of patients with cancer & is leading the development cell therapies.
Rafael López Schietekat
Founder & Managing Director of Diagnostikare
Follow Rafael López Schietekat:
About Diagnostikare: The first data-driven patient-centric virtual primary care platform in Mexico.
Sandeep Bansal
Founder & CEO of Medic Creations
Dr Bansal graduated from Imperial College London with a MSc in Paediatrics and Child Health. In 2013 he started his General Practitioner training at Oxford Deanery where he was also Trainee Lead, representing Oxford Deanery for the Associates in Training (AiT) committee in their quarterly meetings at Royal College of General Practitioners. From his professional experience and feedback from his peers, DrBansal raised the concerns of poor Information Governance (IG) compliance around sharing patient dataat AiT meetings. With the AiT board’s response of their inability to offer an alternative solution, Dr Bansalcarried out a survey to understand the extent of the problem in 2014. The survey for his 180 colleagues went viral and he received 2050 responses confirming the poor IG compliance practice, predominantly around the use of WhatsApp. In 2014 he set up Medic Creations and created the innovative app MedicBleep to enable secure and reliable clinical communication for primary, secondary and community care. With enabling communication across healthcare organisations and professionals, Medic Bleep empowerstrue interoperability, the future of healthcare management and innovation. Medic Creations was selected for Web Summit Alpha 2015 and is listed in the Journal of mHealth’s top100 Global Digital Companies for 2016 and 2017.
Follow Sandeep Bansal:
About Bennett Coleman and Co Ltd, Harvard Medical School, Medic Creations, shl.vc: Revolutionising Communications in Healthcare
Nader Alaghband
Co-Founder & CEO of Ampersand Health
Follow Nader Alaghband:
About Ampersand Health: Ampersand creates innovative digital medicines for complex long term conditions, using behavioural and data-science.
Amit Nathwani
Founder & Chief Scientific Officer of Freeline
Amit is renowned for his pioneering work on gene therapy for haemophilia B, and was first to show successful correction of bleeding diathesis in patients with severe haemophilia B. Amit is the Director of the Katharine Dormandy Haemophilia Centre at the Royal Free Hospital, and a Senior NIHR Investigator. He is also Professor of Haematology at UCL. He graduated in Medicine from the University of Aberdeen in 1984. In 1997 he moved to St. Jude Children’s Research Hospital, Memphis, USA, to work with Dr Arthur Nienhuis on adeno-associated virus mediated gene transfer. Here he started his pioneering work on gene therapy for haemophilia B. In 2001 he returned to University College London as a Senior Lecturer in Haematology and a Consultant to the National Blood Services in the UK. He was the first to show successful correction of bleeding diathesis in patients with severe haemophilia B, using a distinct gene transfer approach developed in collaboration with Dr’s Davidoff and Nienhuis at St Jude Children’s Research Hospital.
Follow Amit Nathwani:
About Freeline: Freeline Therapeutics is a biotechnology company focused on developing liver directed gene therapies for a range of diseases.
Mohammed Tayeb
Co-Founder and Chief Operations Officer of Medicalchain
Internet entrepreneur and founder of several technology and e-commerce start-ups. Mohammed specialises in bringing together technological efficiencies to the business world. Most recent start-up is ReadyCache, a web acceleration platform using Multi-CDN technology. Mohammed holds an Executive MBA from University of Oxford and a BSc in eCommerce from Brunel University, London.
Follow Mohammed Tayeb:
About Dynistics, Medicalchain: Medicalchain is a decentralized platform that enables secure, fast and transparent exchange and usage of medical data.
Abdullah Albeyatti
CEO & Co-Founder of Medicalchain
Dr Albeyatti graduated from Imperial College London as a doctor in 2011. He has always had a passion for innovation and problem solving and has developed solutions to inefficiencies he found whilst working in the UK National Health Service. In 2016 he co-founded Medicalchain, initially as Discharge Summary – an application used in hospitals to generate accurate medical reports on patients, before they are discharged. Dr Albeyatti’s career in medicine started with surgical training in London and has moved on to general practice with a view to continuing his ENT passion and furthering his management aspirations. He continues to work in Accident and Emergency to sharpen his clinical skill set.
Follow Abdullah Albeyatti:
About dischargesummary.co.uk, Medicalchain, MyClinic, NHS, NHS England: Medicalchain is a decentralized platform that enables secure, fast and transparent exchange and usage of medical data.
John E. Milad
CEO & Founder of Quanta
John E. Milad is a global healthcare executive, board member, investor, speaker and author. He has a career spanning over 25 years, with experience working in various senior positions in the healthcare sector, including NBGI Ventures, Atlas Venture, Nitec Pharma and Nomura. Currently, John is Chief Executive Officer and founding board member at Quanta Dialysis Technologies, where he recently raised $245m in Series D funding. An executive with international experience in building and growing successful healthcare companies, John had the vision and belief that core technology of managing fluidics on a disposable cartridge could be developed into a portable hemodialysis device with the potential to address multiple unmet needs in the $93 billion global dialysis market. John is a regular speaker and panelist at global medtech and investment conferences and has co-authored 4 peer-reviewed papers.
Follow John E. Milad:
About NBGI Ventures, Quanta: Quanta develops an advanced haemodialysis systems for use in the home and clinic.
Ali Rezaei Haddad
CEO and Founder of NeuroNav
Ali is a neurosurgical resident in London and an NHS Clinical Entrepreneur. Prior to this, he completed his Academic Foundation Training in the Medical Sciences Division at the University of Oxford undertaking research in the field of neuroimaging. He graduated with first class honours in Neurosciences BSc at Imperial College London, and he holds honorary research positions at the University of Oxford and St George’s Medical School. Ali co-founded the internationally acclaimed GoodSAM app used by the NHS, in which clinically trained individuals sign up as volunteers to respond to life-threatening emergency calls. He also directed and curated the Imagining the Future of Medicine at the Royal Albert Hall in partnership with TEDMED, attended by a live audience of 5,000 people. Inspired by the lack of user friendly and affordable neuronavigation solutions worldwide, he founded NeuroNav to democratise access to neurosurgery navigation solutions.
Follow Ali Rezaei Haddad:
About Imperial College Healthcare NHS Trust, NeuroNav: An augmented reality neuronavigation platform powered by computer vision and machine learning.
Carina Cunha
Co-Founder & CEO of Be Nosy
Carina is a business strategist and inventor of Nosy with passion for science, sales and marketing. In her former role as MD and Launcher of Crimson Education Europe, she created sales, marketing and service delivery teams from scratch, achieving millions in ARR and 150%+ YoY growth. Prior to working with startups Carina was corporate strategist at JPMorgan, Strategy Consultant at Accenture, Investment Banker at Credit Suisse, and a fashion model with Elite. Carina is also an innovation and commercial consultant through Meta Strategy and Founders Intelligence where she helps startups and scale-ups find product-market fit and corporates build new revenue lines. She has a B.A. from Columbia University and PgD. from the University of Edinburgh.
Follow Carina Cunha:
About Be Nosy: Nosy is a MedTech startup developing wearable air filter and air pollution tracking network.
Yiannis Kiachopoulos
CEO, Co-Founder of Causaly
Follow Yiannis Kiachopoulos:
About Causaly: Causaly is teaching computers to read all knowledge in Biomedicine
Artur Saudabayev
Co-Founder, CTO of Causaly
Follow Artur Saudabayev:
About Causaly: Causaly is teaching computers to read all knowledge in Biomedicine
David O’Rourke
Co-Founder and Chief Scientific Officer (CSO) & Chief Innovation Officer (CIO) of Bea Fertility
David O’Rourke is the Chief Operating Officer and Co-Founder of Bea Fertility.
Follow David O’Rourke:
About Bea Fertility, Vitrolife: Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking.
Zubair Ahmed
CEO & Founder of MedicSpot
Follow Zubair Ahmed:
About MedicSpot: MedicSpot gives patients convenient and quick access to healthcare using the latest advancements in telemedicine
Richard Vincent
CEO & Co-Founder of FundamentalVR
Richard has 20+ years’ experience of building international businesses and has throughout his career sought opportunities for positive market disruption through technological application. It was this desire that led him to co-found FundamentalVR to help address an age-old problem for the medical market; how to create safe, realistic, measurable spaces to learn and develop skills. In his role as CEO Richard is responsible for building a world class team of medical, learning and technologist who together can realise the company’s ambition of creating the world’s first global, haptically enabled, low cost ‘flight simulator for surgeons’.
Follow Richard Vincent:
About Fundamental Surgery, FundamentalVR: FundamentalVR delivers VR haptic ‘flight simulators’ for surgery creating a safe, measurable & repeatable space to refine to refine skills.
Chris Scattergood
CRO & Founder of FundamentalVR
A key part of his role at Fundamental, Chris visits leading surgeons, educators, hospital groups, bodies and device manufacturers across the US to understand their educational needs and requirements for successful integration into our learning platform, and continue to develop our product to support those needs. As one of the co-founders of Fundamental, in 2014 Chris and his co founder saw the opportunity to invest in Virtual Reality as the next tech platform after mobile to revolutionise the way we communicate, share and learn together. From his experience in the Healthcare sector, it was clear that VR presented a clear opportunity to make a real difference in way education could be delivered for Health care professionals.
Follow Chris Scattergood:
About Fundamental Surgery, FundamentalVR: FundamentalVR delivers VR haptic ‘flight simulators’ for surgery creating a safe, measurable & repeatable space to refine to refine skills.
Vibhor Gupta
Director and Founder of Pangaea Data
Vibhor is an entrepreneur in residence at Nexgen Capital Ventures where he is involved in deal flow and leading creative technological opportunties within Life Sciences following his breadth of experience in industry and academia over the last 16 years. Prior to this role, Vibhor has served in various positions ranging from technical bioinformatics roles, sales (of software technology products) and executive management. Vibhor started and built the European business for Quantum Secure, which was an enterprise software solutions provider and was successfully acquired in 2015. Most recently he served as a Senior Vice President at Seven Bridges Genomics which provides cloud (SaaS) based bioinformatics solutions for the Life Sciences industry. Vibhor has also worked as a management and technology consultant for Deloitte. His academic career focused on bioinformatics, epigenetics and molecular biology studies in oncology and infectious diseases. Vibhor has access to an extensive network in the industry and was recently honoured as an advisor to two prominent organisations, HealthEx and FrontLine Genomics. He was also a Technology Lead on ASIS’s UK committee, which is the largest professional body for CSOs and CISOs in the world.
Follow Vibhor Gupta:
About Pangaea Data: Pangaea Data provides a machine learning-based software solution making scientific and clinical data more meaningful.
Global CEO & Co-Founder of Andiamo
Follow Naveed Parvez:
About Andiamo, UnLtd: Custom medical wearables platform
Mathieu de Beaumont
Co-Founder / Director of Dementech
Co-Founder of Dementech Neurosciences
Follow Mathieu de Beaumont:
About : Neurology & Psychology experts
Michel Rabhi
Founder and Director of Dementech
Owner and Director at Dementech Neurosciences
Follow Michel Rabhi:
About : Neurology & Psychology experts
Pablo Graiver
President and Founder of Antidote.me
Pablo Graiver is Co-Founder of Antidote Technologies Ltd. (a/k/a TrialReach Ltd.) and serves as its Chief Executive Officer and Executive Director. Pablo Graiver served as Vice President of Business Development, Europe of Kayak Software Corporation. He has over 12 years of entrepreneurial and management experience in the online industry. He was an early member of NetJuice, one of the largest Internet incubators in Europe; MD at Donde Comprar.com, the first e-commerce directory in Spanish; and later co-founder and Vice President of Strategy at Kelkoo, acquired by Yahoo! in 2004. Pablo Graiver set up and launched Kayak.com in Europe, and served as European Sales Director at ValueClick (NASDAQ: VCLK). He studied Biology and Business Administration at UAM in Madrid.
Follow Pablo Graiver:
About Antidote.me: Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.
Alex Hamilton
Founder of DocTap
Alex had the idea for DocTap whilst struggling to get an NHS GP appointment for his chronic back pain arising from his time in the Armed Forces. When he was unable to find a convenient, affordable GP surgery he knew he had to build one. 18 months later, DocTap was born. He is delighted to have attracted such a talented team to help build DocTap. And here they are.
Follow Alex Hamilton:
About DocTap: DocTap provide convenient, expert GP care from their network of central London clinics.
Daniel Faber
Founder of DocTap
Follow Daniel Faber:
About DocTap: DocTap provide convenient, expert GP care from their network of central London clinics.
Ali Moiyed
CEO & Founder of Aerobit Health
Follow Ali Moiyed:
About Aerobit Health: Breathing New Life Into Asthma Care
Krishan Ramdoo
CEO and Founder of Tympa Health Technologies LTD
Krishan Ramdoo is the CEO and Founder of TympaHealth Technologies.
Follow Krishan Ramdoo:
About Tympa Health Technologies LTD: TympaHealth are a team of doctors and technology experts united in their vision of helping the world to hear.
Alex Hooi
Chief Medical Officer / Founder of Callaly
Inventor of the Tampliner®, and a co-founder at Callaly.He is also an NHS Gynaecologist, Consultant Specialist and Clinical Director of the Barking Havering and Redbridge University Hospitals NHS Trust and Fellow of the Royal College of Obstetricians and Gynaecologists.
Follow Alex Hooi:
About Callaly: Callaly is a period care company that develops and manufactures innovative feminine care products.
Thang Vo-Ta
CEO & Co-Founder of Callaly
Co-founder & CEO at Callaly.Thang is a graduate of MIT and started his career in Goldman Sachs in NYC & London.
Follow Thang Vo-Ta:
About Callaly: Callaly is a period care company that develops and manufactures innovative feminine care products.
Paweł Sieczkiewicz
Co Founder & CEO of Telemedi
Graduate of Warsaw University of Technology, experienced project manager (web/mobile apps), php programmer. Founder of an SSF software house. 2x champion of Poland in kickboxing.
Follow Paweł Sieczkiewicz:
About Telemedi: Trusted partner in digital healthcare
Napala Pratini
Co-Founder of Habitual
Napala Pratini is the Founder at Habitual.
Follow Napala Pratini:
About Habitual: Digital therapeutics & nutritional treatment for type 2 diabetes reversal.
Ian Braithwaite
CEO & Co-Founder of Habitual
Ian Braithwaite is the CEO and Co-Founder at Habitual.
Follow Ian Braithwaite:
About Habitual: Digital therapeutics & nutritional treatment for type 2 diabetes reversal.
Agnieszka Chomka
Co-Founder and Head of R&D of BioMe Oxford
Agnieszka is an intestinal immunologist at the Kennedy Institute for Rheumatology, University of Oxford. Her main research interests focus on the microbial-host interactions in the large intestine. She was awarded the prestigious Wellcome Trust scholarship at the University of Oxford to conduct her research into the role of a tissue-resident regulatory immune cell population in the gut. Agnieszka has published her results in top peer-review research journals.
Follow Agnieszka Chomka:
About BioMe Oxford, Globe Life Sciences: Unlocking your gut microbiome by developing a medical device for targeted and non-invasive sampling
Guido Franzoso
Scientific Founder of Kesios Therapeutics
Franzoso joined Imperial College London in June 2007 and is Head of the Centre for Cell Signalling and Inflammation and Professor and Chair of Signal transduction and Inflammation. He was previously at the University of Chicago for 10 years. Franzoso, is the principal founder of Kesios Therapeutics, a spin-out from Imperial College London founded in 2012. Franzoso’s work is highly regarded by the scientific community, as evidenced by numerous high-impact publications in journals, such as, Nature, Science, Cell, Immunity, Nature Cell Biology and Cancer Cell and he has been awarded substantial funding to pursue his research. Recognising the need to translate this research into healthcare benefit, Franzoso was able to raise £3.7M from the MRC for a multi-centre Phase I/IIa trial of DTP3 in multiple myeloma and he has also successfully achieved substantial project funding for both basic and clinical research from the MRC, CRUK and NIH (US). Franzoso owns several patents on intellectual property related to his research. Franzoso holds a medical degree from the University of Padua medical school, Italy and a Ph.D. in microbiological sciences from the Institute of Microbiology at the University of Padua.
Follow Guido Franzoso:
About Imperial College London, Kesios Therapeutics: Kesios Therapeutics, a London, UK-based oncology drug discovery company
Ashley Rudland
Co-Founder of Circular Wave
Ashley Rudland is the co-founder of Circular Wave. He was the founder and principal consultant at DeepSilver Solutions. He is also a former co-founder and CTO at World City Limited.
Follow Ashley Rudland:
About Circular Wave: Temporary Staffing Platform for the NHS
Edward Ungar
Co-Founder & CEO of Pharmacierge
Edward Ungar is a Co-founder at Pharmacierge.
Follow Edward Ungar:
About Pharmacierge: The free e-prescribing service chosen by Private GPs and Consultants to deliver medication to their patients nationwide
Robert Ungar
Co-Founder of Pharmacierge
Robert Ungar is a Co-Founder at Pharmacierge.
Follow Robert Ungar:
About Pharmacierge: The free e-prescribing service chosen by Private GPs and Consultants to deliver medication to their patients nationwide
Ioannis Papakonstantinou
Founder of Echopoint Medical
Ioannis holds a PhD in Optical Interconnections from University College London. After his PhD, he joined Sharp Laboratories of Europe to work on the design and fabrication of photonic nanostructures for Optical Displays. Subsequently, he joined CERN-European Organisation of Nuclear Research where he led the work on fibre optic communication systems for particle physics detectors. He is currently a Professor of Photonics and Nanofabrication in the Department of Electronic and Electrical Engineering at UCL where he leads the Photonic Innovations Lab (www.ee.ucl.ac.uk/pilab). The mission of his lab is to exploit the synergies between nanotechnology and photonics for energy and biomedical applications. Ioannis has authored/co-authored over 130 journal publications and conference proceedings and is the holder of over 10 patent families.
Follow Ioannis Papakonstantinou:
About Echopoint Medical: Echopoint Medical is a medtech company
Richard Colchester
Founder of Echopoint Medical
Richard was born in Ipswich, U.K., in 1990. He received the MSci degree in physics from Imperial College London, London, U.K., in 2012, and the MRes degree in photonic systems development from University College London, London, U.K., in 2013. He finished his Ph.D. in Medical Physics and Biomedical Engineering at University College London in 2016. On completion of his Ph.D. he was award an EPSRC Doctoral Prize Fellow at University College London to develop an all-optical ultrasound imaging system for cardiovascular procedures. Since, he has received a Royal Academy of Engineering research fellowship to continue his work in this field and establish his research. His research interests include developing interventional medical imaging systems based on laser-generated ultrasound and photoacoustics.
Follow Richard Colchester:
About Echopoint Medical: Echopoint Medical is a medtech company
Katerina Spranger
Founder and CEO of Oxford Heartbeat
Katerina is the Fellow of the Royal Academy of Engineering. She holds a PhD in Biomedical Engineering from the University of Oxford and was previously a researcher in AI at the Sony Computer Science Laboratory in Paris.
Follow Katerina Spranger:
About Oxford Heartbeat, Royal Academy of Engineering: Oxford Heartbeat makes cardiovascular surgery more accurate and safe.
Basil Omar
Founder & Chief Commercial Officer of CHAIN Biotechnology
Basil has a PhD in Physics from Loughborough University and MBA from Warwick Business School. He has held senior technical management roles in semiconductors, electronic displays and advanced materials with Philips Electronics and Sharp Corporation. Basil also has a background in Management Consultancy with PRTM (now PwC) and Grant Thornton, and has held senior business development and marketing roles at Transco/National Grid and Green Biologics. Basil via Woodbridge Innovation has supported numerous early stage companies in a range of high tech fields including clean energy and industrial biotech. Basil launched and ran the University of Gloucestershire’s business incubation hubs and is co-founder of the Gloucestershire Angel Investment Network. Basil is a farming and classic car enthusiast.
Follow Basil Omar:
About Bristol Business School, CHAIN Biotechnology: CHAIN Biotechnology is a microbiome therapeutics company with a novel drug development platform targeting chronic gut-related diseases.
Ema Kufel
Co-Founder, CEO of Prosoma
Co-Founder/CEO, Ema is an (MSc) Marketing Communications graduate and an expert in healthcare communications. Ema has vast experience in managing projects developing digital strategies within the National Health Service and the Department of Health in the UK. She is passionate about healthcare and innovation, key components of Prosoma.
Follow Ema Kufel:
About Prosoma: At Prosoma, we design world-leading digital therapeutics solutions for Oncology.
Marek Ostrowski
Founder of Prosoma
Founder, Marek finished Philosophy at the University of Wrocław, and then a post-graduate accredited Psychotherapy course, and Simonton’s Therapy Course. He specialises in working with oncological patients. From 2008, the founder and shareholder of a tech company, in which he was responsible for the development, innovation and management of strategic projects.
Follow Marek Ostrowski:
About Prosoma: At Prosoma, we design world-leading digital therapeutics solutions for Oncology.
Kate Hersov
Founder & Chief Medical Officer of Jumo Health
Follow Kate Hersov:
About Jumo Health: Jumo Health provides educational content and tools to help children and families understand, manage, and own their health.
Barry Shrier
Co-Founder & CEO of The Health-Tech Innovation LABS
Barry Shrier is Founder and CEO of Health-tech Innovation LABS, Barry is a serial entrepreneur with a history of successful exits .
Follow Barry Shrier:
About GIANT Health Events, The Health-Tech Innovation LABS: The Health-Tech Innovation LABS (HTI-LABS) are a group of businesses that improve the healthcare sector.
Alexandra Hussenot
Founder & CEO of Immersionn
Alexandra is the founder of Immersionn, the world’s first VR Discovery Engine and she is also the UK lead for ‘Women in Immersive Technologies’, a community of 1000 members that aims to empower European women working in XR. She is also 1 in 10 members of the UK5G Creative Industries working group reporting the department in charge of Digital, Medias, Culture and Sport (DCMS). Prior to this, Alexandra pursued an international business career at insurance firm, Allianz, managing an £80M global business. She has also worked all over Europe during her 11 years at Sony Ericsson (now Sony Mobile) and has solid experience designing and launching software and service products, particularly covering user experience design and continuous improvements. She also lead large scale operations for mobile phone repairs and remanufacturing.
Follow Alexandra Hussenot:
About Immersionn: Immersionn is a content discovery company. We allow people to discover VR content they would never find
Mikael Landau
Co-Founder of Heydoc
Mikael Landau is Co-Founder at Heydoc Limited.
Follow Mikael Landau:
About Heydoc: The integrated clinical system for managing your patients’ medical data and admin tasks.
Charlie Groome
Founder of Everna
Follow Charlie Groome:
About Everna: Everna is a biotech company developing novel therapeutics.
George Frodsham
Founder & CEO of MediSieve
George Frodsham founded MediSieve after being awarded his PhD in biochemical engineering from University College London (UCL), during which he developed the magnetic blood filter. As well as being a physicist and engineer, George is an entrepreneur. George was awarded a BBSRC Enterprise Fellowship from the Royal Society of Edinburgh in 2014. Since 1996, only 180 individuals have benefited from this highly competitive and prestigious programme. George has also completed the Entrepreneurship Summer School programme at the London Business School. This equipped him to research target markets and industries and turn his visions into viable businesses.
Follow George Frodsham:
About MediSieve: MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
Gemma Timms
Founder & COO of VitaeVR
Gemma Timms is an executive at Hakluyt and the co-founder of Vitae VR.
Follow Gemma Timms:
About VitaeVR: Medical devices for early diagnosis of cognitive disease
Peter Coe
Co-Founder of Xperiome
Peter Coë, co-founder and content director, has been with the company from the outset. He has more than three decades’ experience in communications, originally as a reporter, editor and presenter for TV-am, the BBC and Sky News, and has led complex healthcare programmes in multiple languages and countries since 2007.
Follow Peter Coe:
About Xperiome: Xperiome is a global healthtech company that delivers deep insights in rare disease experiences
Julie Walters
Founder & Executive Director of Xperiome
Follow Julie Walters:
About Xperiome: Xperiome is a global healthtech company that delivers deep insights in rare disease experiences
Kitty Liao
Founder & CEO of Ideabatic
Royal Academy of Engineering 2018 Enterprise Fellow, Ambassador at THE Port Association, Switzerland. Ten years experience in multi-disciplinary system design and R&D, including low temperature systems, superconducting cavity diagnostics systems and design for low-resource settings.
Follow Kitty Liao:
About Ideabatic: Ideabatic is solving the most challenging humanitarian problems by delivering innovative solutions and devices.
Wayne Danter
Founder, President & CEO of Cotinga Pharmaceuticals
Dr. Wayne Danter is the President, Chief Executive Officer and a Director. Previously, he held the position of Chief Scientific Officer at COTI. Dr. Danter is the inventor of the CHEMSAS® process and one of the founders of COTI. He trained at the University of Western Ontario in Internal Medicine and Clinical Pharmacology. Prior to founding COTI, Dr. Danter was an Associate Professor of Medicine at the University of Western Ontario. His clinical focus, in addition to his teaching role, at the University was in General Cardiology, Cardiovascular Diseases associated with HIV a1d Cardiovascular Risk Management. Dr. Danter’s initial research focused on the medical application of Artificial Intelligence (AI) technologies to disease diagnosis and outcome prediction. The primary aspect of his research has focused on developing Hybrid AI models to pattern the relationship between molecular strudzure and biological activity. This research has resulted in a sophisticated process for decomposing complex molecules into critical elements that permit accurate molecular structure activity modeling (CHEMSAS). His research has been published in peer-reviewed publications and he has presented at numerous international meetings. Dr. Danter is a pioneer in the evolving interface between AI Technologies and pharmacotherapeutics. These AI technologies are anticipated to play a major role in 21st century drug development.
Follow Wayne Danter:
About Cotinga Pharmaceuticals: Cotinga Pharmaceuticals discovers and develops drug therapies for diseases.
Javier Gonzalez-Zabaleta
Founder & CEO of Medimsight
Javier Gonzalez-Zabaleta was the main designer of the cloud model to bring worldwide medical imaging artificial intelligence solutions accessible to everyone. As one of the pioneers in this space, he has achieved a good experience in both market space and the technology. During last 10 years, he focused at the same time in business development, including direct communication with clinicians, and the understanding of the clinical trials market. Always open to talk, partnering and sharing knowledge. At the university, he studied computer science before made a master degree in computer vision making research in areas like multiple sclerosis and Alzheimer disease. Following his dream, empowering researchers and building super doctors, he has lived in Ponferrada, Madrid and now in London.
Follow Javier Gonzalez-Zabaleta:
About FundRx, Medimsight: Medical image triage and biomarkers analysis for precision medicine.
Kevin Bambury
Co-Founder & CBO of ONCOassist® (Portable Medical Technology Ltd.)
Kevin recently graduated from the Masters of Electronic Business in UCC with a 1st class honours degree. He has previous experience working in start-ups as the co-founder of Dingadeal.com and having worked with Sigojoven.com in Spain. He worked with AIB in Brand Management and marketing focusing on the area of sponsorships. He managed AIBs sponsorship of the GAA club championships in 2007. Prior to this he studied a BA in English and Geography and a Higher Diploma in Management and Marketing.
Follow Kevin Bambury:
About ONCOassist® (Portable Medical Technology Ltd.): The go-to app for oncology professionals.
Richard Bambury
Co-Founder & CMO of ONCOassist® (Portable Medical Technology Ltd.)
Richard is a medical oncologist at Memorial Sloan Kettering Cancer Center in NYC. He is heavily involved in patient care and academic research. He is the recipient of numerous awards including the the Ainsworth Scholarship from UCC in 2012, the John Quale Travel fellowship in 2013 and is a lead co-investigator on a Prostate Cancer Foundation-Movember Challenge Award worth $1 million in 2014. In his career to date he has presented over 40 original research abstracts at national and international oncology conferences including ESMO, ASCO and ASCO GU. His work has been published in peer reviewed journals including the New England Journal of Medicine. He is dedicated to improving cancer patient care through ongoing innovation and research.
Follow Richard Bambury:
About ONCOassist® (Portable Medical Technology Ltd.): The go-to app for oncology professionals.
Faii Ong
Founder and CEO of GyroGear
Faii Ong is the founder and CEO of GyroGear.
Follow Faii Ong:
About GyroGear: GyroGear is developing a wearable to help individuals with hand tremors.
Lise Pape
Founder of Walk With Path
Lise is the Founder of Walk With Path and the inventor of the two products. She holds a double Masters in Innovation Design Engineering from the Royal College of Art and Imperial College London. Prior to that, she worked for Invest in Denmark at the Royal Danish Embassy in London, where she was responsible for attracting foreign companies to Denmark within the sectors of life sciences and clean technologies. She has also worked in online advertising for AOL’s Advertising.com and in finance for J.P. Morgan. Lise holds a BSc in Human Biology from King’s College London.
Follow Lise Pape:
About Future Care Capital, Walk With Path, Walk With Path: Walk With Path is a mobility company providing active wearables and data insights to improve human function.
Anna Perdrix Rosell
Co-Founder & Co-CEO of Sixfold Bioscience
Anna Perdrix Rosell is the Co-Founder & Co-CEO at Sixfold Bioscience.
Follow Anna Perdrix Rosell:
About Sixfold Bioscience: Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.
Asif Qasim
Founder and CEO of MedShr
Follow Asif Qasim:
About Bradford Grammar School, Croydon Health Services, King’s College Hospital NHS Foundation Trust, MedShr: MedShr facilitates an online network that enables doctors to connect and share data and knowledge with each other.
Neel Patel
Founder & Chief Executive Officer of ZiO Health
Follow Neel Patel:
About ZiO Health: ZiO Health has developed proprietary pocket-sized technology, bringing lab testing to the point of use.
Duncan Hall
Founder and CEO of Triumph Research Intelligence
Duncan has over fifteen years of consultancy experience, thirteen of which have been within clinical R&D in both CRO and Pharma businesses. Duncan started Triumph in 2002 with the aim of building a global business which would be focused in improving the delivery, quality and value of clinical systems. Duncan now takes a primarily strategic role in TRI, but still performs client delivery roles where possible.
Follow Duncan Hall:
About Triumph Research Intelligence: Triumph Research Intelligence is a risk-Based Monitoring Company.
Xavier Bernal
Founder and Chief Executive Officer of Findoc
Xavier Bernal is Founder and Chief Executive Officer at Findoc.
Follow Xavier Bernal:
About Findoc: Platform for booking appointments with healthcare professionals.
Sylvain Vuillen
Founder & Chief Operating Officer of Findoc
Sylvain Vuillen is serves as a Chief Operating Officer at Findoc.
Follow Sylvain Vuillen:
About Findoc: Platform for booking appointments with healthcare professionals.
Herbert Oakes
Founder & CEO of NOXSUDOR THERAPEUTICS LIMITED
Herbert Oakes, non-executive director, is an investment banker and builder of high technology life sciences companies. He is currently a Managing Director of Oakes, Lyman & Co. Limited an investment banking firm specialising in high-tech healthcare; a Managing director of Hycroft Advisors, a global investment banking firm specialising in arranging capital for private equity partnerships; and CEO of NoxSudor Therapeutics Limited, a start-up medical business developing a therapy for hot flashes and night sweats for menopausal women. He is an advisor of Wilton Corporate Finance Limited.
Follow Herbert Oakes:
About NOXSUDOR THERAPEUTICS LIMITED: First prescription medical device to control sweating
Hawaa Budraa
Founder of PlaqueChecker
Follow Hawaa Budraa:
About PlaqueChecker: PlaqueChecker is an app where you can track, monitor and diagnose the health of your teeth and gums.
Toby Basey-Fisher
Co-Founder & CEO of Entia
Toby Basey-Fisher serves as a Co-Founder & CEO at Entia.
Follow Toby Basey-Fisher:
About Entia, Imperial College London: Entia is a medical technology company that specializes in improving access to blood test.
Bruce Hellman
CEO and Co-Founder of uMotif
Bruce Hellman is the CEO and Co-Founder of uMotif.
Follow Bruce Hellman:
About uMotif: UMotif is a scalable and engaging patient-centred data capture platform for modern research.
Cameron Shaw
Founder and COO of Virax Biolabs
Cameron Shaw is the founder and Chief Operations Officer at Virax Biolabs.
Follow Cameron Shaw:
About Virax Biolabs: Virax Biolabs is an innovative Biotechnology company focused on the prevention, detection and diagnosis of viral diseases
Brendon Noble
Founder of Regenerys
A medical charity funding the development of the next generation of stem cell related therapies. This ground breaking work is our passion and the therapies that will result from the work will change medicine and clinical outcomes for millions of patients. Follow @ukscf on Twitter
Follow Brendon Noble:
About Regenerys: Regenerys develops and sells regenerative medicine products in the streams requiring bioprocessing and biostorage.
Guang Zhong Yang
Co-Founder of Smart Surgical Appliances
Guang-Zhong Yang is Founder of Smart Surgical Appliances Limited. Guang-Zhong Yang serves at Institute of Biomedical Engineering.
Follow Guang Zhong Yang:
About Smart Surgical Appliances: Smart Surgical Appliances is a medical device company, developing sensor-enabled surgical instrumentation.
Ara Darzi
Co-Founder of Smart Surgical Appliances
Prof. Ara Darzi, KBE MD, FRCS, FRCSI, FACS, co-founded SynaptiQ Ltd. in 2001. Prof. Darzi is the Founder of Smart Surgical Appliances Limited. He serves as the Head of Scientific Advisory Board, Director and Member of Scientific Advisory Board of SynaptiQ Ltd. He served as a Hunterian Professor of the Royal College of Surgeons of England. He holds the Chair of Surgery at Imperial College School of Medicine and is also the Tutor in Minimal Access Surgery at the Royal College of Surgeons in England. He is the James IV traveling fellow for 1999/2000, and is also a Council Member of the Association of Coloproctologists of Great Britain and Ireland, The Association of Endoscopic Surgeons of Great Britain and Ireland, and the Society of Minimal Invasive Therapy. He is also the Chairman of the London Committee for the Modernisation of the National Health Service, which is charged with recommending how best to modernise the NHS. He was appointed as Advisor on Surgery to the Department of Health. He serves as Vice Chairperson at Sidra Medical and Research Centre. He conferred a Fellow of the American College of Surgeons. His main clinical and academic interest is Minimal Invasive Therapy, including Imaging and Biological research. He has co-authored over 100 peer review publications and five books on surgery. Prof. Darzi received an honorary Knighthood in December 2002 in recognition of his service to the United Kingdom National Health Service. Prof. Darzi obtained his fellowship in Surgery from the Royal College of Surgeons in Ireland and an M.D. degree from Trinity College, Dublin.
Follow Ara Darzi:
About Smart Surgical Appliances, The Institute of Cancer Research: Smart Surgical Appliances is a medical device company, developing sensor-enabled surgical instrumentation.
Jamie Wilson
Founder and CEO of hometouch
Jamie Wilson is a UK doctor and founder of HomeTouch. His company offers an online marketplace for finding experienced care professionals locally for elderly and personal care. The carers have an app that allows them to respond to job enquiries, monitors their care activities and manages their contracts. HomeTouch is supported by organisations like the Nominet Trust and Technology Strategy Board.
Follow Jamie Wilson:
About hometouch: hometouch is a home-care marketplace connecting families looking for home care to professional carers.
Shafi Ahmed
Co-Founder & Chief Medical Officer of Medical Realities
Ahmed is a highly experienced general and colorectal surgeon, operating at The Royal London Hospital. In 2007, he was appointed as a Consultant General, Colorectal and Laparoscopic Surgeon at Barts and the London NHS trust. In 2014, he performed the world first live-stream of an operation using Google Glass, which was watched live by 13000 students around the world.
Follow Shafi Ahmed:
About Hearthy, Medical Realities: A new business offering medical training products, specializing in virtual reality and augmented reality.
Mark Lowdell
CSO, Founder & CMO of INmuneBIO
CSO INmuneBio Inc.
Follow Mark Lowdell:
About Achilles Therapeutics, INmuneBIO, The Royal Free: INmune Bio is developing therapies that harness the patient’s immune system to treat cancer.
Charles Ball
Co-Founder and Commercial Manager of Chronomics
Charles Ball is the Co-Founder and Commercial Manager at Chronomics.
Follow Charles Ball:
About Chronomics: Tech-bio company, providing access to a ‘bio-infrastructure’ to simplify and speed-up the use of biomarkers to improve everyday decisions.
Toby Call
Co-Founder of Chronomics
Toby Call is the Co-Founder of Chronomics.
Follow Toby Call:
About Chronomics: Tech-bio company, providing access to a ‘bio-infrastructure’ to simplify and speed-up the use of biomarkers to improve everyday decisions.
Daniel Elías Martín Herranz
Co-Founder and CSO of Chronomics
Daniel Elías Martín Herranz is the Co-Founder and CSO at Chronomics.
Follow Daniel Elías Martín Herranz:
About Chronomics: Tech-bio company, providing access to a ‘bio-infrastructure’ to simplify and speed-up the use of biomarkers to improve everyday decisions.
AF_initDataCallback({key: \’ds:1\'” alt=”” class=”wp-image-14850″ width=”154″ height=”152″/>Marek Tarcak
Founder of Red Med Technologies
Founder at Red Med Technologies
Follow Marek Tarcak:
About Red Med Technologies: Efficiently-designed medical devices for fast-growing medical sectors
Antimo Farid Mir
CEO and Founder of AREEA
Follow Antimo Farid Mir:
About AREEA: Pioneering urban health
Michael O’Neill
Co-Founder and Director R&D of Inflection Biosciences
Michael O’Neill has more than 20 years’ experience working in the pharmaceutical industry. He was a Senior Research Scientist and Portfolio Manager at Eli Lilly for much of this time where he was responsible for developing project plans for the selection of projects and for their progression from discovery through to important development milestones. He established his own consulting business, Eolas, to help early stage companies to organize their research along commercial lines, becoming accomplished at building highly streamlined development plans. He has built consortia of commercial and academic groups to apply for major EU grants. Previously Dr. O’Neill was Head of Laboratory at Almirall and a Research Neuroscientist at Merck. He has authored over 80 papers, book chapters, patents and abstracts and is Honorary Visiting Senior Lecturer at the Science Policy Research Unit at the University of Sussex. He holds a BA Psychology from UCC and a PhD from QUB Belfast.
Follow Michael O’Neill:
About Inflection Biosciences: Inflection Biosciences is a company that develops small-molecule therapeutics for the treatment of cancer.
Elettra Bianchi Dennerlein
Founder & co-CEO of My Online Therapy
Elettra Bianchi Dennerlein is the Founder and co-CEO at My Online Therapy.
Follow Elettra Bianchi Dennerlein:
About My Online Therapy: MyOnlineTherapy, a mobile mental health company, is the first of its kind virtual psychology clinic.
Davidson Ateh
Co-Founder & CEO of BioMoti
Davidson is an entrepreneur operating in the life sciences. He has an interdisciplinary scientific background in bioengineering and was a past recipient of the prestigious Royal Society of Edinburgh/BBSRC Enterprise Fellowship. Davidson has significant technology translation experience including proof-of-concept studies, IP protection, non-dilutive grant applications, partnering, licensing and raising investment. He has won awards for his scientific and commercial activities. Davidson is a co-inventor of the Oncojan™ drug delivery platform, co-founder of BioMoti and leads product and business development activities.
Follow Davidson Ateh:
About BioMoti: BioMoti seeks to transform the treatment of cancer by targeted delivery of therapeutics to the intracellular space of cancer cells
Charles Large
Founder and CEO of Autifony Therapeutics
Charles Large received his first degree and PhD from the University of Bristol and has more than 20 years of experience of drug discovery and development in the pharmaceutical industry. Before founding Autifony, he was Director of Molecular and Cellular Biology within the Neuroscience Centre of Excellence for Drug Discovery at GlaxoSmithKline, and has worked on programs focused on schizophrenia, Alzheimer’s disease, epilepsy, bipolar disorder, and major depression. He is an expert on drugs that modulate voltage gated ion channels and their application to neurological and psychiatric disorders. He has built up a reputation in the field of sodium channel blocking drugs, and has collaborated widely with academic groups. He has authored over 50 papers, book chapters and patents relating to ion channel modulators.
Follow Charles Large:
About Autifony Therapeutics: Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.
Douglas Higgins
Founder & Director of Mujo Mechanics
Douglas Higgins is the Founder & Director at Mujo Mechanics.
Follow Douglas Higgins:
About Mujo Mechanics: Mujo Mechanics provides smart devices and intelligent cloud platform for a data-driven approach to musculoskeletal health.
Alya Shakir
Founder & Managing Director of Private Walk-In Clinic
Managing Director of the Harley Health Centre Group
Follow Alya Shakir:
About : Private medical services in the City of London.
Rafael Michaeli
CoFounder of SAVA
Follow Rafael Michaeli:
About SAVA: The first effortless continuous molecular tracker unlocking human perfomance
Ivaylo Yosifov
Co-Founder and CTO of FindMeCure
Follow Ivaylo Yosifov:
About FindMeCure: FindMeCure helps anyone to easily find future treatments and apply for participation in studies within a few clicks.
Oner Avara
CEO & Founder of My Next Match
Follow Oner Avara:
About My Next Match: The ultimate tool for the sports federations to govern, including Medical Passports for the athletes, an MMS and online progression/grading
David Greenberg
CEO & Founder of Eave
Follow David Greenberg:
About Eave: Eave (formerly EarTex) is a startup developing the next generation of hearing protection and communication technology.
Helen Townley
Non-executive Director & Co-Founder of Xerion Healthcare
Helen Townley joined University of Oxford as Associate Professor in 2020.
Follow Helen Townley:
About University of Oxford, Xerion Healthcare: Xerion Healthcare is the technology commercialization company of University of Oxford.
James Moore
Co-Founder of Health Development & Performance Network
Follow James Moore:
About Health Development & Performance Network: Health Development & Performance Network provides education and learning courses to health professionals.
Ergys Peka
Founder / Director of 6 Degrees Network
Follow Ergys Peka:
About : A hybrid networking company, for ordinary individuals to meet extraordinary people within their field of practice.
Hugo Macedo
CEO & Founder of Smart Separations Ltd
Hugo is the founder and CEO of Smart Separations Ltd. He has over 11 years of experience in entrepreneurship which helped him founding this start-up company that has developed a proprietary filter that can be tailored to suit many different applications in the poorly explored but very large microfiltration market, from biotechnology to food & drink processing. Throughout his PhD in Biomedical Engineering, Hugo was constantly challenged with new and diverse tasks, in a multidisciplinary environment, where he breathed skills from chemical engineering to stem cell technology, including membrane technology, hydrodynamics, stem cell culture and bioprocessing, human blood production, amongst many others. This provided him with the right tools to create the first “3D hollow fibre bioreactor for the production of human red blood cells” – a system design that he patented. This work was featured in different magazines, including the cover page of The Chemical Engineer (TCE) in 2011, selected as one of “Ten life-changing ideas under research at UK universities” by the Research Councils UK and shortlisted for the highly prestigious IChemE Awards in 2011. Hugo currently holds 2 patents and is passionate for innovation leading to improve people’s quality of life – a vision that he has shared with Smart Separation
Follow Hugo Macedo:
About Smart Separations Ltd: Smart Separations is a limited company based in London UK that has patented an innovative microfiltration technology.
